This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
6 - 8 June, 2023
Postillon Hotel AmsterdamDigital Experience: All Sessions Live-streamed 6-8 June, 2023

Léo Marx, PhD
Medicinal Chemistry Project Manager at Debiopharm Research & Manufacturing


Employed at Debiopharm since 2017, where I currently work as a Medicinal Chemistry Project Manager in the field of oncology. I am involved in the discovery programs focusing on both small molecules and ADCs.

I have a background in chemical engineering and organic chemistry. I obtained my PhD from the University of Oxford in 2014, which focused on the syntheses natural product and I then carried an industrial postdoctoral work at Bayer in Wuppertal working in the discovery of ADCs based on a new linker-payload platforms.

Agenda Sessions

  • A Novel Antibody Drug Conjugate Linker Enabling Production of ADCs with High Drug to Antibody Ratios and Fast Payload Release for Improved Efficacy